Start here if you're new
what it is
Synchrony provides store-branded credit cards and other financing through retailer partnerships.
how it gets paid
Last year Synchrony Financ made $18.5B in revenue. Diversified & Value was the main engine at $6.3B, or 34% of sales.
why it's growing
Revenue grew 2.5% last year. Revenue was $13.7B, up 190% vs. prior year on the supplied filing.
what just happened
Synchrony posted $2.04 EPS versus $2.10 expected, a 2.9% miss.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
50/100 earnings predictability — expect surprises
8.6x trailing p/e — the market's not buying it — or you found a deal
1.5% dividend yield — cash in your pocket every quarter
9.2% return on capital — nothing to write home about
xvary composite: 74/100 — average
What they do
Synchrony provides store-branded credit cards and other financing through retailer partnerships.
You do not need shoppers to love Synchrony. You need them to swipe at checkout. Partners (retailers and brands that sell its credit products) give you that reach without building stores. It runs 5 sales platforms with more than 20,000 employees. That is a lean setup for a lender. Diversified & Value alone is 34% of purchase volume, so one platform already carries the load.
How they make money
$18.5B
annual revenue · their business grew +2.5% last year
Diversified & Value
$6.3B
Home & Auto
$4.6B
Digital
$4.6B
Health & Wellness
$1.7B
Lifestyle
$1.3B
The products that matter
private-label cards and checkout lending
Point-of-Sale Financing
$18.5B revenue · core business
it's effectively the whole $18.5B revenue engine. when retail partners keep volume flowing and credit stays clean, this is a strong cash business. when approvals tighten, growth gets quiet fast.
entire story
partner-driven retail credit programs
Retail Partner Network
14% return on equity
the partner network is the distribution edge. A 14% return on equity says those relationships still produce decent economics, even with revenue growth at just 2.5%.
distribution moat
capital return via buybacks and dividend
Shareholder Payout
1.5% yield · buyback support
you are not here for a 1.5% yield alone. The bigger support is buybacks, which management is using to help EPS while revenue growth stays modest.
eps lever
Key numbers
+21%
upside to target
The $97 target sits 21% above $80.19, so Wall Street is paying you to wait.
$18.5B
annual revenue
That is the top line. It tells you the business is still big enough to matter.
9.35
fy2026 eps
EPS means profit per share. At $9.35, the stock trades at 8.6x next year's profit.
1.5%
dividend yield
Yield means cash back each year. At 1.5%, you are getting paid, but not much.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 50 / 100
- long-term debt $14.4B (33% of capital)
- return on equity 12% — $0.12 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in SYF 3 years ago → it's now worth $25,690.
The index would have given you $14,770.
source: institutional data · total return
What just happened
missed estimates
Synchrony posted $2.04 EPS versus $2.10 expected, a 2.9% miss.
Revenue was $13.7B, up 190% vs. prior year on the supplied filing. The miss was small, but the stock still cares because lenders get judged on each dollar of profit.
$13.7B
revenue
$2.04
eps
2.9%
surprise
the number that mattered
The 2.9% miss mattered because $0.06 of EPS still moves a lender priced at 8.6x earnings.
-
synchrony financial likely closed 2025 in respectable fashion.strong fundamentals, including better-than-expected-earnings and improving credit quality trends in recent quarters have resulted from targeted credit actions that have bolstered performance of late. these more rational credit actions consist of restricted credit line increases in order to shift the portfolio away from risky, subprime borrowers and encourage higher payment rates and stabilize charge offs.
-
meanwhile, stock buybacks ought to support eps before the plan expires in the second quarter.
-
granted, the busy holiday shopping season likely saw a pickup in retail traffic.
-
but tightened loan approvals and a lower interest rate likely resulted in slow loan growth and flat net interest income in the december period.
-
macroeconomic uncertainty and political overhang may linger.
source: company earnings report and consensus, 2025
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is consumer credit deterioration in private-label cards.
med
credit quality slips
Synchrony's whole model depends on borrowers paying on time. if delinquencies or charge-offs move the wrong way, profitability can compress quickly.
This is an $18.5B revenue lender with a 19.2% quarterly margin. weaker credit would hit both earnings power and the valuation multiple.
med
loan growth stays slow
management can tighten approvals to protect the book, but safer underwriting usually means slower new volume. that trade-off is already visible in modest 2.5% revenue growth.
If growth stays soft while buybacks do the work, the market may keep treating SYF like an 8.6x earnings stock.
med
buyback support fades
the current repurchase plan is expected to expire in Q2 2026. if it is not renewed, one of the cleanest EPS support levers gets weaker.
A 1.5% dividend yield alone is not enough to carry the shareholder-return story.
med
regulatory and compliance costs rise
consumer finance is heavily supervised. stricter compliance requirements or legal pressure can raise costs even if headline revenue looks fine.
On a B++ balance sheet with $14.4B of long-term debt, higher friction matters more than it would for a cleaner lender.
If credit weakens while revenue remains near 2.5% growth, the low multiple stops looking like an opportunity and starts looking appropriate.
source: institutional data · regulatory filings · risk analysis
Pay attention to
risk
credit quality
watch charge-off trends, payment behavior, and any sign that tighter underwriting is no longer enough to protect margins.
metric
revenue vs. EPS
if EPS keeps rising much faster than revenue, ask how much is operating improvement and how much is buybacks doing the cosmetic work.
calendar
Q2 2026 buyback decision
the current repurchase plan is expected to expire in Q2 2026. renewal matters because capital return is part of the thesis.
trend
loan growth
you want to see originations recover without credit standards being loosened enough to create a later problem.
Analyst rankings
short-term outlook
top 5%
momentum score 1 — the highest rating. in human-speak, analysts think this stock has stronger near-term price momentum than almost everything else they cover.
risk profile
average
stability score 3 means middle-of-the-pack risk. not a bunker stock, not a disaster candidate.
chart momentum
top 20%
technical score 2 points to above-average relative performance. the stock has been acting better than the business sounds.
earnings predictability
50 / 100
earnings can swing around more than you would like. that comes with the territory when consumer credit is part of the product.
source: institutional data
Institutional activity
institutions have been net buying for 3 consecutive quarters — 442 buyers vs. 389 sellers in 3q2025. total institutional holdings: 0.4B shares. net buying for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$60
$134
$80
current price
$97
target midpoint · +21% from current · 3-5yr high: $115 (+45% · 11% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive